Why this paper is being considered
A randomized trial of about 800 patients starting antiretroviral therapy in Mozambique finds that financial incentives alone raise medication adherence by 10.6 percentage points while incentives plus reminders raise it by 24.3. A model of inattention and imperfect memory rationalises the complementarity. It bears on how incentive programs for chronic-disease adherence should be designed. An evaluation would focus on the adherence measure, the mechanism tests, and cost-effectiveness against simpler reminders.
AI-generated criterion ratings and reasoning
Scores come from AI prioritization; the accompanying explanations include AI-assisted source checks. These are provisional judgments, separate from human ratings and commissioned evaluations.
Decision relevance
8.0/10
HIV medication (ART) adherence is a first-order determinant of treatment success, viral suppression, and onward transmission, and adherence-support strategies are an active design question for PEPFAR, the Global Fund, WHO, and national health ministries. Evidence that modest financial incentives raise adherence by ~10.6pp — and that pairing incentives with reminder/attention supports may be needed because memory and inattention blunt their effect — bears directly on how much to spend on incentives versus complementary reminder systems. Cost-effectiveness-oriented funders (GiveWell, Open Philanthropy global health) and program designers could use these estimates to weigh adherence-support packages against alternatives.
- Paper claim to check Financial incentives alone increase HIV medication adherence by 10.6 percentage points in a randomized trial in Mozambique. Source abstract
Value of added scrutiny
9.0/10
The paper has an NBER record and a project page at the University of Michigan. One independent newsletter surfaced in search, though we did not confirm how it uses the paper. We found no guideline, program adoption or critique.
Timing
9.0/10
This is a newly released NBER working paper with no indicated journal publication, so it is at the peak-value stage for independent evaluation: the results are novel, not yet peer-reviewed, and feedback on identification, the incentive-vs-reminder mechanism decomposition, and external validity could still shape the published version. For RCTs, early scrutiny of design and analysis choices is especially valuable.
- Source record Publication-stage and date evidence should be checked in the linked paper record. NBER
Methodological potential
8.0/10
No methodological rationale is stored.
- Paper claim to check Financial incentives alone increase HIV medication adherence by 10.6 percentage points in a randomized trial in Mozambique. Source abstract
Prominence
9.0/10
The scoring model estimated prominence from the paper's venue, authors, institutional setting, and visibility. The model did not supply a criterion-specific explanation. Current public-attention status: Limited public attention found.
Likely influence
7.0/10
The scoring model estimated how far the findings could shape later research or decisions, without supplying a criterion-specific explanation. Current public-attention status: Limited public attention found. See public-attention evidence below.
What the paper says
Source abstract · Full source abstract recovered from the NBER paper page; HTML entities and whitespace normalized.
Financial incentives are widely used to encourage beneficial behaviors, but their effectiveness may be limited by inattention and imperfect memory. We study this in a randomized trial of HIV medication adherence in Mozambique. Financial incentives alone increase adherence by 10.6 percentage points, while pairing incentives with reminders increases adherence by 24.3 percentage points. We develop a model in which inattention to daily adherence and imperfect memory of payment eligibility reduce incentive effectiveness and show that reminders mitigate both frictions. Detailed medication refill data support the model’s predictions. The results suggest combining incentives with reminders can substantially increase program effectiveness.
Claims to check
- Financial incentives alone increase HIV medication adherence by 10.6 percentage points in a randomized trial in Mozambique.
- The effectiveness of financial incentives is limited by inattention and imperfect memory, implying that incentives may need to be paired with reminder or attention-supporting interventions.
- The relative and combined effects of incentives versus memory/attention supports can be identified within the experimental design, informing the optimal design of adherence-support packages.
Methodological or theoretical issues flagged for evaluation
No structured evaluation-challenges field is stored.
Opus 5.5 re-evaluation (experimental)
Read with care. This is an experimental re-evaluation by a different model (Claude Opus 5.5, 2026-10-01). Across a calibration sample Opus scored about 15 points lower than GPT-5.5, so 15 points are added to compare it with GPT-5.5 scores. The calibration is a small sample (n=44) and is not human-validated, and the two models disagree about the order of papers within the top group. The AI score at the top of this page is the usual evaluation-priority score shifted by the difference between the adjusted Opus score and the earlier holistic score; the synthesis uses that shifted value, and the unshifted score is shown beside it. On the dashboard you can switch the Opus scores off. Read the methods note.
Different reference score. The earlier score for this paper came from an older Opus run (opus), not GPT-5.5, so no +15 offset is applied: the shift is the Opus 5.5 score minus that earlier score, which assumes the two Opus versions share a scale.
Opus rationale (AI-generated)
This is a new NBER working paper by Hang Yu, Jared Stolove and Dean Yang, reporting a randomized trial of HIV medication adherence in Mozambique. It is squarely in the global-health and LMIC development-economics core that has historically made up a large share of what The Unjournal evaluates. The headline result is that incentives alone raise adherence by 10.6pp, while incentives plus reminders raise it by 24.3pp. That bears directly on how HIV programmes (ministries of health, PEPFAR implementers, Global Fund grantees, NGOs) design adherence support, and more broadly on whether conditional transfers anywhere should bundle cheap reminders. The behavioural model of inattention and imperfect memory of payment eligibility gives the result some generality beyond HIV. The paper is unpublished and has no visible independent review, so evaluators could add value. Useful checks: whether refill-based adherence maps onto viral suppression, whether a reminders-only comparison exists, whether the structural mechanism tests really discriminate between rival explanations, the cost-effectiveness, and persistence after incentives end. Concerns: the welfare pathway depends on clinical outcomes that the abstract does not report, and financial incentives for ART are not yet standard policy, so near-term uptake may be limited. Still, the combination of a prominent author, a fresh working paper, a policy-relevant RCT and an LMIC health setting makes it a strong candidate.
Dashboard details and provenance
Full AI dashboard scoring rationale
This is a fresh NBER working paper reporting a randomized trial of financial incentives for HIV medication adherence in Mozambique, with a design that also probes the behavioral mechanisms (inattention, imperfect memory) that limit incentive effectiveness. It sits squarely in two of Unjournal's strongest cause areas — global health in LMICs and development economics — and the headline result (incentives alone raise adherence by 10.6 percentage points) is directly decision-relevant for how PEPFAR, the Global Fund, national HIV programs, and health-focused funders design adherence interventions. Dean Yang is an established development economist and the NBER stamp guarantees visibility, but as an un-peer-reviewed working paper the result has had essentially no independent scrutiny, so an Unjournal evaluation adds clear marginal value precisely at the moment feedback is most actionable. The main honest caveat is that some adherence-incentive RCTs have mixed external validity, and the behavioral-mechanism claims (memory/inattention as the binding constraint) will need careful evaluation of how those channels are identified.
AI decision-relevance rationale
HIV medication (ART) adherence is a first-order determinant of treatment success, viral suppression, and onward transmission, and adherence-support strategies are an active design question for PEPFAR, the Global Fund, WHO, and national health ministries. Evidence that modest financial incentives raise adherence by ~10.6pp — and that pairing incentives with reminder/attention supports may be needed because memory and inattention blunt their effect — bears directly on how much to spend on incentives versus complementary reminder systems. Cost-effectiveness-oriented funders (GiveWell, Open Philanthropy global health) and program designers could use these estimates to weigh adherence-support packages against alternatives.
AI timing assessment
This is a newly released NBER working paper with no indicated journal publication, so it is at the peak-value stage for independent evaluation: the results are novel, not yet peer-reviewed, and feedback on identification, the incentive-vs-reminder mechanism decomposition, and external validity could still shape the published version. For RCTs, early scrutiny of design and analysis choices is especially valuable.
Public attention and use
The paper has an NBER record and a project page at the University of Michigan. One independent newsletter surfaced in search, though we did not confirm how it uses the paper. We found no guideline, program adoption or critique.
This was a quick check (a few targeted searches). Treat the gaps below as especially uncertain.
Project page listing / discoverability
A project page for the Mozambique trial run by the authors' network.
Source: University of Michigan · Relationship: author institution
Newsletter public mention
A newsletter piece appeared in the results for this study. We did not read it closely enough to confirm that it discusses this paper.
Source: Nominal News · Relationship: relationship not checked
What the search did not establish
- This was a quick check; treat the gaps as especially uncertain.
- No EA Forum or LessWrong discussion surfaced.
- The most decision-relevant next signal is whether HIV programs pilot incentive-plus-reminder bundles.
Quick search checked 2026-10-01. Search scope: Targeted exact-title searches across the open web, institutional and author pages, news and public social-media results, EA Forum/LessWrong, and policy/white-paper contexts. Evidence records distinguish commissioning or report use from independent discussion, media attention, indexing, and post-publication policy use. A search miss is reported as uncertainty, not proof of absence. Entries with check_depth "quick" rest on roughly one to two searches and should be read as especially uncertain; entries checked on 2026-10-01 were added for the shortlist of papers without human ratings.
Human feedback so far
The privacy-safe aggregate contains 1 current rating: 0 team and 1 public. The human mean is 90.0/100. The team has not made a final prioritization decision.
No written discussion is public. Private and team-only text is never copied to this page.